93
Views
29
CrossRef citations to date
0
Altmetric
Article

Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early‐stage gastric carcinoma

, , , , &
Pages 754-760 | Received 05 May 2003, Accepted 29 Feb 2004, Published online: 08 Jul 2009

References

  • Karpeh MS, Jr, Brennan MF. Gastric carcinoma. [Review]. Ann Surg Oncol 1998;5:650–6.
  • Everett SM, Axon AT. Early gastric cancer in Europe. [Review]. Gut 1997;41:142–50.
  • Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122: 1450–9.
  • To CT, Tsao MS. The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancers. [Review]. Oncol Rep 1998;5:1013–24.
  • Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, et al. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary beast cancer. Clin Cancer Res 1998;4:659–64.
  • Takigawa N, Segawa Y, Maeda Y, Takata I, Fujimoto N. Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients. Lung Cancer 1997;17:211–8.
  • Gohji K, Nomi M, Niitani Y, Kitazawa S, Fujii A, Katsuoka Y, et al. Independent prognostic value of serum hepatocyte growth factor in bladder cancer. J Clin Oncol 2000;18:2963–71.
  • Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A, et al. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 1997; 75: 673–77.
  • Niki M, Isozaki H, Toyoda M, Ishibashi T, Fujii K, Nomura E, et al. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma. Hepato-Gastroenter- ology 1999;46:568–73.
  • Han SU, Lee JH, Kim WH, Cho YK, Kim MW. Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J Surg 1999;23:1176–80.
  • Wu CW, Chi CW, Su TL, Liu TY, Lui WY, P’eng FK. Serum hepatocyte growth factor level associate with gastric cancer progression. Anticancer Res 1998;18:3657–9.
  • Fukuura T, Miki C, Inoue T, Matsumoto K, Suzuki H. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer 1998;78:454–9.
  • Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 1996;77:602–6.
  • Yokota T, Saito T, Teshima S, Kikuchi S, Kunii Y, Yamauchi H. Lymph node metastasis in early gastric cancer: how can surgeons perform limited surgery? Int Surg 1998;83:287–90.
  • Grem J. The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract. Curr Opin Oncol 1997;9: 380–7.
  • Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Cianetti A, et al. The role of serum and gastric juice levels of carcinoembryonic antigen CA 19.9 and CA 72.4 in patients with gastric cancer. J Cancer Res Clin 1998;124:450–5.
  • Duraker N, Celik AN. The prognostic significance of preoperative serum CA19–9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol 2001;76:266–71.
  • Beppu K, Uchiyama A, Morisaki T, Nakamura K, Noshiro H, Matsumoto K, et al. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. Anticancer Res 2000;20:1263–7.
  • Wu CW, Li AF, Chi CW, Chung WW, Liu TY, Lui WY, et al. Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. Oncol Rep 1998;5:817–22.
  • Park WS, Oh RR, Kim YS, Park JY, Shin MS, Lee HK, et al. Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas. APMIS 2000;108:195–200.
  • Hori K, Shiota G, Kawasaki H. Expression of hepatocyte growth factor and c-Met receptor in gastric mucosa during gastric ulcer healing. Scand J Gastroenterol 2000;35:23–31.
  • Takahashi M, Hata Y, Terano A. Effect of sofalcone on the expressin of hepatocyte growth factor (HGF) and a brief review of HGF In the stomach. J Clin Gastroenterol 1997;25 Suppl 1: S21–7.
  • Nakamura K, Morisaki T, Sugitani A, Ogawa T, Uchiyama A, Kinukawa N, et al. An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis. Cancer 1999;85: 1500–5.
  • Kunisaki C, Shimada H, Nomura M, Akiyama H. Appropriate lymph node dissection for early gastric cancer based on lymph node metastases. Surgery 2001;129:153–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.